date:Nov 02, 2018
the common stock, which was up 32% from $288 million, or 83c per share, in the previous years third quarter. Lifting earnings in the quarter were mark-to-market adjustments and a one-time income tax adjustment for provisional estimates related to the adoption of U.S. tax reform.
Net sales in the quarter reached $3,469 million, up 7% from $3,246 million primarily because of the RXBAR acquisition in October 2017 and the consolidation of Nigerian distributor Multipro in May of this year. Organic